Cargando…

Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model

Background: Recently, the duodenum has garnered interest for its role in treating metabolic diseases, including type 2 diabetes (T2DM). Multiple sessions of external photobiomodulation (PBM) in previous animal studies suggested it resulted in improved hyperglycemia, glucose intolerance, and insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Se Hee, Kwon, Jinhee, Do, Eun-Ju, Kim, So Hee, Kim, Eun Sil, Jeong, Jin-Yong, Bae, Sang Mun, Kim, Sang-Yeob, Park, Do Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654760/
https://www.ncbi.nlm.nih.gov/pubmed/36359885
http://dx.doi.org/10.3390/cells11213490
_version_ 1784829012743290880
author Min, Se Hee
Kwon, Jinhee
Do, Eun-Ju
Kim, So Hee
Kim, Eun Sil
Jeong, Jin-Yong
Bae, Sang Mun
Kim, Sang-Yeob
Park, Do Hyun
author_facet Min, Se Hee
Kwon, Jinhee
Do, Eun-Ju
Kim, So Hee
Kim, Eun Sil
Jeong, Jin-Yong
Bae, Sang Mun
Kim, Sang-Yeob
Park, Do Hyun
author_sort Min, Se Hee
collection PubMed
description Background: Recently, the duodenum has garnered interest for its role in treating metabolic diseases, including type 2 diabetes (T2DM). Multiple sessions of external photobiomodulation (PBM) in previous animal studies suggested it resulted in improved hyperglycemia, glucose intolerance, and insulin resistance with a multifactorial mechanism of action, despite the target organ of PBM not being clearly proven. This study aimed to determine whether a single session of a duodenal light-emitting diode (LED) PBM may impact the T2DM treatment in an animal model. Methods: Goto–Kakizaki rats as T2DM models were subjected to PBM through duodenal lumen irradiation, sham procedure, or control in 1-week pilot (630 nm, 850 nm, or 630/850 nm) and 4-week follow-up (630 nm or 630/850 nm) studies. Oral glucose tolerance tests; serum glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide, and insulin levels; liver chemistry and histology; and gut microbiome in the PBM, sham control, and control groups were evaluated. Results: In the 1-week study, duodenal dual-wavelength (D, 630/850 nm) LED PBM showed improved glucose intolerance, alkaline phosphatase and cholesterol levels, and weight gain than other groups. The D-LED PBM group in the 4-week study also showed improved hyperglycemia and liver enzyme levels, with relatively preserved pancreatic islets and increased serum insulin and GLP-1 levels. Five genera (Bacteroides, Escherichia, Parabacteroides, Allobaculum, and Faecalibaculum) were significantly enriched 1 week after the D-LED PBM. Bacteroides acidifaciens significantly increased, while Lachnospiraceae significantly decreased after 1 week. Conclusion: A single session of D-LED PBM improved hyperglycemia and hepatic parameters through the change of serum insulin, insulin resistance, insulin expression in the pancreatic β-cells, and gut microbiome in T2DM animal models.
format Online
Article
Text
id pubmed-9654760
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96547602022-11-15 Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model Min, Se Hee Kwon, Jinhee Do, Eun-Ju Kim, So Hee Kim, Eun Sil Jeong, Jin-Yong Bae, Sang Mun Kim, Sang-Yeob Park, Do Hyun Cells Article Background: Recently, the duodenum has garnered interest for its role in treating metabolic diseases, including type 2 diabetes (T2DM). Multiple sessions of external photobiomodulation (PBM) in previous animal studies suggested it resulted in improved hyperglycemia, glucose intolerance, and insulin resistance with a multifactorial mechanism of action, despite the target organ of PBM not being clearly proven. This study aimed to determine whether a single session of a duodenal light-emitting diode (LED) PBM may impact the T2DM treatment in an animal model. Methods: Goto–Kakizaki rats as T2DM models were subjected to PBM through duodenal lumen irradiation, sham procedure, or control in 1-week pilot (630 nm, 850 nm, or 630/850 nm) and 4-week follow-up (630 nm or 630/850 nm) studies. Oral glucose tolerance tests; serum glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide, and insulin levels; liver chemistry and histology; and gut microbiome in the PBM, sham control, and control groups were evaluated. Results: In the 1-week study, duodenal dual-wavelength (D, 630/850 nm) LED PBM showed improved glucose intolerance, alkaline phosphatase and cholesterol levels, and weight gain than other groups. The D-LED PBM group in the 4-week study also showed improved hyperglycemia and liver enzyme levels, with relatively preserved pancreatic islets and increased serum insulin and GLP-1 levels. Five genera (Bacteroides, Escherichia, Parabacteroides, Allobaculum, and Faecalibaculum) were significantly enriched 1 week after the D-LED PBM. Bacteroides acidifaciens significantly increased, while Lachnospiraceae significantly decreased after 1 week. Conclusion: A single session of D-LED PBM improved hyperglycemia and hepatic parameters through the change of serum insulin, insulin resistance, insulin expression in the pancreatic β-cells, and gut microbiome in T2DM animal models. MDPI 2022-11-03 /pmc/articles/PMC9654760/ /pubmed/36359885 http://dx.doi.org/10.3390/cells11213490 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Min, Se Hee
Kwon, Jinhee
Do, Eun-Ju
Kim, So Hee
Kim, Eun Sil
Jeong, Jin-Yong
Bae, Sang Mun
Kim, Sang-Yeob
Park, Do Hyun
Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model
title Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model
title_full Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model
title_fullStr Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model
title_full_unstemmed Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model
title_short Duodenal Dual-Wavelength Photobiomodulation Improves Hyperglycemia and Hepatic Parameters with Alteration of Gut Microbiome in Type 2 Diabetes Animal Model
title_sort duodenal dual-wavelength photobiomodulation improves hyperglycemia and hepatic parameters with alteration of gut microbiome in type 2 diabetes animal model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654760/
https://www.ncbi.nlm.nih.gov/pubmed/36359885
http://dx.doi.org/10.3390/cells11213490
work_keys_str_mv AT minsehee duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT kwonjinhee duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT doeunju duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT kimsohee duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT kimeunsil duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT jeongjinyong duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT baesangmun duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT kimsangyeob duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel
AT parkdohyun duodenaldualwavelengthphotobiomodulationimproveshyperglycemiaandhepaticparameterswithalterationofgutmicrobiomeintype2diabetesanimalmodel